| 1 |
Lin OS, Kozarek RA, Cha JM.Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidencebased review of published prospective and retrospective studies[J]. Intest Res, 2014, 12(4): 268-274.
|
| 2 |
Ferlay J, Shin HR, Bray F, et al.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
|
| 3 |
Nathan DM, Buse JB, Davidson MB, et al.Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes[J]. Diabetologia, 2009, 52(1): 17-30.
|
| 4 |
Papanas N, Maltezos E, Mikhailidis DP.Metformin: diamonds are forever[J]. Expert Opin Pharmacother, 2009, 10(15): 2395-2397.
|
| 5 |
Kourelis TV, Siegel RD.Metformin and cancer: new applications for an old drug[J]. Med Oncol, 2012, 29(2): 1314-1327.
|
| 6 |
颜英，汤绍辉，黄秋燕，等．二甲双胍与2型糖尿病患者大肠癌发病风险关系的Meta分析[J]．解放军医学杂志，2015，40(7)：582-586.
|
| 7 |
Brenner H, Kloor M, Pox CP.Colorectal cancer[J]. Lancet, 2014, 383(9927): 1490-1502.
|
| 8 |
Schoenleber SJ, Kurtz DM, Talwalkar JA, et al.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis[J]. Br J Cancer, 2009, 100(9): 1385-1392.
|
| 9 |
Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary? [J]. Control Clin Trials, 1996, 17(1): 1-12.
|
| 10 |
Kjaergard LL, Villumsen J, Gluud C. Correction: reported methodological quality and discrepancies between large and small randomized trials in meta-analyses[J]. Ann Intern Med, 2001, 135(3): 982-989.
|
| 11 |
Chung YW, Han DS, Park KH, et al.Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea[J]. Dis Colon Rectum, 2008, 51(5): 593-597.
|
| 12 |
Eddi R, Karki A, Shah A, et al.Association of type 2 diabetes and colon adenomas[J]. J Gastrointest Cancer, 2012, 43(1): 87-92.
|
| 13 |
Lee JH, Jeon SM, Hong SP, et al.Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer[J]. Dig Liver Dis, 2012, 44(12): 1042-1047.
|
| 14 |
Wong P, Weiner MG, Hwang WT, et al.Insulin therapy and colorectal adenomas in patients with diabetes mellitus[J]. Cancer Epidemiol Biomarkers Prev, 2012, 21(10): 1833-1840.
|
| 15 |
Kanadiya MK, Gohel TD, Sanaka MR, et al.Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy[J]. J Diabetes Complications, 2013, 27(5): 463-466.
|
| 16 |
Cho YH, Ko BM, Kim SH, et al.Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus? [J]. Intest Res, 2014, 12(2): 139-145.
|
| 17 |
Kim YH, Noh R, Cho SY, et al.Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes[J]. Intest Res, 2015, 13(2): 145-152.
|
| 18 |
Marks AR, Pietrofesa RA, Jensen CD, et al.Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus[J]. Cancer Epidemiol Biomarkers Prev, 2015, 24(11): 1692-1698.
|
| 19 |
Jain D, Chhoda A, Uribe J. Effect of insulin and metformin combination treatment on colon adenoma and advanced adenoma among DM II[J]. J Gastrointest Cancer, 2016, 47(4): 404-408.
|
| 20 |
Han MS, Lee HJ, Park SJ, et al.The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma[J]. Int J Colorectal Dis, 2017.
|
| 21 |
Higurashi T, Hosono K, Takahashi H, et al.Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre doubleblind, placebo-controlled, randomised phase 3 trial[J]. Lancet Oncol, 2016, 17(4): 475-483.
|
| 22 |
He XK, Su TT, Si JM, Sun LM.Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: a meta-analysis[J]. Medicine(Baltimore), 2016, 95: e2749.
|
| 23 |
Singh S, Singh H, Singh PP, et al.Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis[J]. Cancer Epidemiol Biomarkers Prev, 2013, 22(12): 2258-2268.
|